Whipple's triad
| Whipple's triad | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hypoglycemia, neuroglycopenia, relief of symptoms after glucose administration |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Insulinoma, insulin overdose, non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) |
| Risks | |
| Diagnosis | Clinical evaluation, blood glucose measurement |
| Differential diagnosis | |
| Prevention | |
| Treatment | Glucose administration, treatment of underlying cause |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Whipple's triad is a collection of three criteria that suggest a patient's symptoms result from hypoglycemia caused by an insulinoma, a type of pancreatic tumor. The triad was named after Allen Whipple, an American surgeon who first described the condition in 1938.
Criteria[edit]
The three criteria of Whipple's triad are:
- Symptoms consistent with hypoglycemia
- Low plasma glucose at the time of symptoms
- Relief of symptoms when glucose levels are raised
Symptoms[edit]
Symptoms of hypoglycemia can vary from person to person, but often include:
Diagnosis[edit]
Whipple's triad is often used as a diagnostic tool in the evaluation of patients with suspected insulinoma. However, it is not definitive proof of the condition. Further tests, such as a fasting test or imaging studies, may be required to confirm the diagnosis.
Treatment[edit]
Treatment for insulinoma typically involves surgical removal of the tumor. In some cases, medication may be used to manage symptoms until surgery can be performed.